Skip to main content
Top
Published in: Inflammation 2/2012

01-04-2012

Circulating Cytokine Levels in Acute Pancreatitis—Model of SIRS/CARS Can Help in the Clinical Assessment of Disease Severity

Authors: Ivan Gunjaca, Josip Zunic, Mihaela Gunjaca, Zdenko Kovac

Published in: Inflammation | Issue 2/2012

Login to get access

Abstract

The aim of our study was to evaluate the pro- and anti-inflammatory cytokine response during acute pancreatitis and its predictive value on severity of disease. A hospital-based prospective clinical study was conducted. Twenty patients with acute pancreatitis were enrolled during a 12-month period. Plasma concentrations of TNF-α, IL-1β, IL-6, and IL-10 were determined at days 1, 2, 3, 6, and 9. The patient population was analyzed by type of acute pancreatitis. Severity was defined according to the Atlanta criteria for assessing severity of acute pancreatitis. Clinical variables were recorded to patients classified in one of two groups: severe acute pancreatitis (SAP group) and mild acute pancreatitis (MILD group). Patients with SAP had significantly higher average levels of IL-6 compared to the MILD group patients (539.2 pg/L vs. 23.4 pg/L, p < 0.0001). Also, the values of IL-10 were significantly higher in patients with SAP (242.4 pg/L vs. 8.1 pg/L, p = 0.003). The values of TNF-α were not significantly different in both groups. The value of IL-6 and IL-10 showed a positive correlation (r = 0.7964, p < 0.0001). Although a relatively small sample of patients was used, we can conclude that the determination of the value of IL-6 and IL-10 can help in the clinical assessment of disease severity.
Literature
1.
go back to reference Banks, P.A., and M.L. Freedman. 2006. Practice guidelines in acute pancreatitis. American Journal of Gastroenterology 101: 2379–2400.PubMedCrossRef Banks, P.A., and M.L. Freedman. 2006. Practice guidelines in acute pancreatitis. American Journal of Gastroenterology 101: 2379–2400.PubMedCrossRef
2.
go back to reference Kusske, A.M., A.J. Rongione, and H.A. Reber. 1996. Cytokines and acute pancreatitis. Gastroenterology 110: 639–642.PubMedCrossRef Kusske, A.M., A.J. Rongione, and H.A. Reber. 1996. Cytokines and acute pancreatitis. Gastroenterology 110: 639–642.PubMedCrossRef
3.
go back to reference Lamy, M., and G. Deby-Dupont. 1995. Is sepsis a mediator–inhibitor mismatch? Intensive Care Medicine 21: S250–S257.PubMedCrossRef Lamy, M., and G. Deby-Dupont. 1995. Is sepsis a mediator–inhibitor mismatch? Intensive Care Medicine 21: S250–S257.PubMedCrossRef
4.
go back to reference American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Critical Care Medicine 1992; 20:864–874. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Critical Care Medicine 1992; 20:864–874.
5.
go back to reference Bone, R.C. 1996. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Annals of Internal Medicine 125: 680–687.PubMed Bone, R.C. 1996. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Annals of Internal Medicine 125: 680–687.PubMed
6.
go back to reference Oberholzer, A., C. Oberholzer, and L.L. Moldawer. 2001. Sepsis syndromes: understanding the role of innate and acquired immunity. Shock 16: 83–96.PubMedCrossRef Oberholzer, A., C. Oberholzer, and L.L. Moldawer. 2001. Sepsis syndromes: understanding the role of innate and acquired immunity. Shock 16: 83–96.PubMedCrossRef
7.
go back to reference Levy, M.M., M.P. Fink, J.C. Marshall, et al. 2003. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Critical Care Medicine 31: 1250–1256.PubMedCrossRef Levy, M.M., M.P. Fink, J.C. Marshall, et al. 2003. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Critical Care Medicine 31: 1250–1256.PubMedCrossRef
8.
9.
go back to reference Osuchowski, M.F., K. Welch, J. Siddiqui, et al. 2006. Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. Journal of Immunology 177: 1967–1974. Osuchowski, M.F., K. Welch, J. Siddiqui, et al. 2006. Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. Journal of Immunology 177: 1967–1974.
10.
go back to reference De Waal Malefyt, R., J. Abrams, B. Bennett, et al. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. The Journal of Experimental Medicine 174: 1209–1220.PubMedCrossRef De Waal Malefyt, R., J. Abrams, B. Bennett, et al. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. The Journal of Experimental Medicine 174: 1209–1220.PubMedCrossRef
11.
go back to reference Howard, M., T. Muchamuel, S. Andrade, et al. 1993. Interleukin 10 protects mice from lethal endotoxemia. The Journal of Experimental Medicine 177: 1205–1208.PubMedCrossRef Howard, M., T. Muchamuel, S. Andrade, et al. 1993. Interleukin 10 protects mice from lethal endotoxemia. The Journal of Experimental Medicine 177: 1205–1208.PubMedCrossRef
12.
go back to reference Bean, A.G.D., R.A. Freiberg, S.A. Andrade, et al. 1993. Interleukin 10 protects mice against staphylococcal enterotoxin B-induced lethal shock. Infection and Immunity 61: 4937–4939.PubMed Bean, A.G.D., R.A. Freiberg, S.A. Andrade, et al. 1993. Interleukin 10 protects mice against staphylococcal enterotoxin B-induced lethal shock. Infection and Immunity 61: 4937–4939.PubMed
13.
go back to reference Van Laethem, J.L., A. Marchant, A. Delvaux, et al. 1995. Interleukin 10 prevents necrosis in murine experimental acute pancreatitis. Gastroenterology 108: 1917–1922.PubMedCrossRef Van Laethem, J.L., A. Marchant, A. Delvaux, et al. 1995. Interleukin 10 prevents necrosis in murine experimental acute pancreatitis. Gastroenterology 108: 1917–1922.PubMedCrossRef
14.
go back to reference Ranson, J.H.C. 1982. Etiological and prognosis factors in human acute pancreatitis: a review. American Journal of Gastroenterology 77: 633–638.PubMed Ranson, J.H.C. 1982. Etiological and prognosis factors in human acute pancreatitis: a review. American Journal of Gastroenterology 77: 633–638.PubMed
15.
go back to reference Knaus, W.A., E.A. Draper, D.P. Wagner, et al. 1985. APACHE II: a severity of disease classification system. Critical Care Medicine 13: 818–829.PubMedCrossRef Knaus, W.A., E.A. Draper, D.P. Wagner, et al. 1985. APACHE II: a severity of disease classification system. Critical Care Medicine 13: 818–829.PubMedCrossRef
16.
go back to reference Le Gall, J.R., S. Lemeshow, and F. Saulnier. 1993. A new Simplified Acute Physiology Score (SAPS II) based on a European North American multicenter study. JAMA 270: 2957–2963.PubMedCrossRef Le Gall, J.R., S. Lemeshow, and F. Saulnier. 1993. A new Simplified Acute Physiology Score (SAPS II) based on a European North American multicenter study. JAMA 270: 2957–2963.PubMedCrossRef
17.
go back to reference Balthazar, E.J. 2002. Acute pancreatitis: assessment of severity with clinical and CT evaluation. Radiology 223: 603–613.PubMedCrossRef Balthazar, E.J. 2002. Acute pancreatitis: assessment of severity with clinical and CT evaluation. Radiology 223: 603–613.PubMedCrossRef
18.
go back to reference Brivet, F.G., D. Emilie, and P. Galanaud. 1999. Pro- and anti-inflammatory cytokines during acute severe pancreatitis: an early and sustained response, although unpredictable of death. Parisian Study Group on Acute Pancreatitis. Critical Care Medicine 27: 749–755.PubMedCrossRef Brivet, F.G., D. Emilie, and P. Galanaud. 1999. Pro- and anti-inflammatory cytokines during acute severe pancreatitis: an early and sustained response, although unpredictable of death. Parisian Study Group on Acute Pancreatitis. Critical Care Medicine 27: 749–755.PubMedCrossRef
19.
go back to reference Mentula, P., M.L. Kylänpää, E. Kemppainen, et al. 2005. Early prediction of organ failure by combined markers in patients with acute pancreatitis. British Journal of Surgery 92: 68–75.PubMedCrossRef Mentula, P., M.L. Kylänpää, E. Kemppainen, et al. 2005. Early prediction of organ failure by combined markers in patients with acute pancreatitis. British Journal of Surgery 92: 68–75.PubMedCrossRef
20.
go back to reference Bradley 3rd, E.L. 1993. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, GA, September 11–13, 1992. Archives of Surgery 128: 586–590.PubMedCrossRef Bradley 3rd, E.L. 1993. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, GA, September 11–13, 1992. Archives of Surgery 128: 586–590.PubMedCrossRef
21.
go back to reference UK Working Party on Acute Pancreatitis. 2005. UK guidelines for the management of acute pancreatitis. Gut 54: 1–9.CrossRef UK Working Party on Acute Pancreatitis. 2005. UK guidelines for the management of acute pancreatitis. Gut 54: 1–9.CrossRef
22.
go back to reference Mayer, J., B. Rau, F. Gansauge, et al. 2000. Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications. Gut 47: 546–552.PubMedCrossRef Mayer, J., B. Rau, F. Gansauge, et al. 2000. Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications. Gut 47: 546–552.PubMedCrossRef
23.
go back to reference Pezzilli, R., P. Billi, R. Miniero, et al. 1995. Serum interleukin-6, interleukin-8, and beta 2-microglobulin in early assessment of severity of acute pancreatitis. Comparison with serum C-reactive protein. Digestive Diseases and Sciences 40: 2341–2348.PubMedCrossRef Pezzilli, R., P. Billi, R. Miniero, et al. 1995. Serum interleukin-6, interleukin-8, and beta 2-microglobulin in early assessment of severity of acute pancreatitis. Comparison with serum C-reactive protein. Digestive Diseases and Sciences 40: 2341–2348.PubMedCrossRef
24.
go back to reference Chen, C.C., S.S. Wang, F.Y. Lee, et al. 1999. Proinflammatory cytokines in early assessment of the prognosis of acute pancreatitis. American Journal of Gastroenterology 94: 213–218.PubMedCrossRef Chen, C.C., S.S. Wang, F.Y. Lee, et al. 1999. Proinflammatory cytokines in early assessment of the prognosis of acute pancreatitis. American Journal of Gastroenterology 94: 213–218.PubMedCrossRef
25.
go back to reference Stimac, D., E. Fisic, S. Milic, et al. 2006. Prognostic values if IL-6, IL-8 and IL-10 in acute pancreatitis. Journal of Clinical Gastroenterology 40: 209–212.PubMedCrossRef Stimac, D., E. Fisic, S. Milic, et al. 2006. Prognostic values if IL-6, IL-8 and IL-10 in acute pancreatitis. Journal of Clinical Gastroenterology 40: 209–212.PubMedCrossRef
26.
go back to reference Messmann, H., W. Vogt, A. Holstege, et al. 1997. Post-ERP pancreatitis as a model for cytokine induced acute phase response in acute pancreatitis. Gut 40: 80–85.PubMed Messmann, H., W. Vogt, A. Holstege, et al. 1997. Post-ERP pancreatitis as a model for cytokine induced acute phase response in acute pancreatitis. Gut 40: 80–85.PubMed
27.
go back to reference Gross, V., R. Andreesen, H.G. Leser, et al. 1992. Interleukin-8 and neutrophil activation in acute pancreatitis. European Journal of Clinical Investigation 22: 200–203.PubMedCrossRef Gross, V., R. Andreesen, H.G. Leser, et al. 1992. Interleukin-8 and neutrophil activation in acute pancreatitis. European Journal of Clinical Investigation 22: 200–203.PubMedCrossRef
28.
go back to reference Beutler, B., and A. Cerami. 1987. Cachectin: more than a tumor necrosis factor. The New England Journal of Medicine 316: 379–385.PubMedCrossRef Beutler, B., and A. Cerami. 1987. Cachectin: more than a tumor necrosis factor. The New England Journal of Medicine 316: 379–385.PubMedCrossRef
29.
go back to reference Paajanen, H., M. Laato, M. Jaakkola, et al. 1995. Serum tumour necrosis factor compared with C-reactive protein in the early assessment of severity of acute pancreatitis. British Journal of Surgery 82: 271–273.PubMedCrossRef Paajanen, H., M. Laato, M. Jaakkola, et al. 1995. Serum tumour necrosis factor compared with C-reactive protein in the early assessment of severity of acute pancreatitis. British Journal of Surgery 82: 271–273.PubMedCrossRef
Metadata
Title
Circulating Cytokine Levels in Acute Pancreatitis—Model of SIRS/CARS Can Help in the Clinical Assessment of Disease Severity
Authors
Ivan Gunjaca
Josip Zunic
Mihaela Gunjaca
Zdenko Kovac
Publication date
01-04-2012
Publisher
Springer US
Published in
Inflammation / Issue 2/2012
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-011-9371-z

Other articles of this Issue 2/2012

Inflammation 2/2012 Go to the issue